Navigation Links
Bone replacement from laser melting
Date:6/16/2010

The body can heal minor bone injuries itself - but with major injuries, it needs help. That's when implants frequently come into use. In contrast to long-term solutions based on titanium, degradable implants are intended to replace the missing pieces of bone only until the fissure closes itself up. That may last months or even years, depending on the size of the defect, the age and health status of the patient. A new implant improves the conditions for the healing process. It emerged from the Resobone project of the federal ministry for education and research, and is sized-to-fit for each patient. Unlike the conventional bony substitutes to date, it is not made up as a solid mass, but is porous instead. Precise little channels permeate the implant at intervals of just a few hundred micrometers. Its precision fit and perfect porous structure, combined with the new biomaterial, promise a total bone reconstruction that was hitherto impossible to achieve, as Dr. Ralf Smeets of the University Medical Center of Aachen summarizes the findings of the first tolerability studies.

The porous canals create a lattice structure which the adjacent bones can grow into. Its basic structure consists of the synthetic polylactide, or PLA for short. The stored granules from tricalcium phosphate (TCP) ensure rigidity and stimulate the bone's natural healing process. As pastes, granulates and semi-finished products, TCP and PLA already have proven to be degradable implants. The body can catabolize both substances as rapidly as the natural bones can regrow. But the material can only be applied in places where it will not be subject to severe stress: Thus, the Resobone implants will primarily replace missing facial, maxillary and cranial bones. Currently, they are able to close fissures of up to 25 square centimeters in size. Their unique structure is made possible through a manufacturing process that was developed at the Fraunhofer Institute for Laser Technology ILT in Aachen for the development of industrial prototypes Selective Laser Melting (SLM): A razor-thin laser beam melts the pulverized material layer-by-layer to structures that may be as delicate as 80 to 100 micrometers.

The patient's computer tomography serves as the template for the precision-fit production of the implants. The work processes from CT imaging, to construction of the implant, through to its completion are coordinated in such precise sequences that the replacement for a defective zygomatic bone can be produced in just a few hours, while a five-centimeter large section of cranium can be done overnight. In addition to the obvious benefits, there is a considerable gain in time during surgery: No custom-fit, degradable implants ever existed before now. During the operation, the surgeon had to cut TCP cubes, or the patient's own previously removed bone material, to size and insert it into the fissure, explains Simon Hges, Project Manager at ILT. In addition, the operations are now fewer in number: Physicians no longer take the bone replacement from the patient's own pelvic bone. Similarly, they can dispense with the countless follow-up operations on children to exchange long-term implants that don't grow as the child matures. We have achieved our project goal: a closed process chain to produce individual bony implants from degradable materials, explains Hges with satisfaction. Now it is up to the project partners which also include implant manufacturers who must turn the results into products.


'/>"/>

Contact: Dipl.-Phys. Simon Hoeges
simon.hoeges@ilt.fraunhofer.de
49-024-189-06360
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related biology news :

1. JDRF partners with LCT to test encapsulated cell replacement therapy for the treatment of diabetes
2. Spallation Neutron Source sees first target replacement
3. Exercise after knee replacement critical
4. Researchers coat titanium with polymer to improve integration of joint replacements
5. Research examines factors in delaying or declining total knee replacement surgery
6. Testosterone replacement theraphy beneficial in men 60 and older
7. MU researcher links hormone replacement therapy to breast cancer
8. Listen-up ladies: Dont postpone knee-replacement surgery
9. Lasers help researchers predict birds preferred habitat
10. Scrubbing chemical-contaminated buildings clean with lasers
11. First X-ray lasers early success brings approval for next-phase facility
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bone replacement from laser melting
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/16/2016)... Nov. 16, 2016 Sensory Inc ., ... security for consumer electronics, and VeriTran , ... retail industry, today announced a global partnership that ... to authenticate users of mobile banking and mobile ... software which requires no specialized biometric scanners, ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... World Technology Awards. uBiome is one of just six company finalists in the ... In addition to uBiome, companies nominated as finalists in this year’s awards include ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... Eutilex Co. Ltd. today announced that it ... A financing. This financing round included participation from DS ... Bio Angel. This new funding brings the total capital ... since its founding in 2015. The ... commercialization of its immuno-oncology programs, expand its R&D capabilities ...
(Date:12/7/2016)... San Diego (PRWEB) , ... December 07, 2016 ... ... safety data from its phase I/II dose escalation and expansion clinical trial for ... 2016 in Vienna, Austria. The purpose of the trial was to determine the ...
Breaking Biology Technology: